Bruker (BRKR) FCF Payout Ratio Growth (1y) (2016 - 2026)
Bruker (BRKR) FCF Payout Ratio Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -16.90% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -8.00% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 0.45% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -88.24% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -11.29% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 27.54% |
| 10 | Bruker | 9.15 Bn | 9.15 Bn | 416.00 Mn | -38.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -38.27% |
| Mar 31, 2026 | -18.10% |
| Dec 31, 2025 | -26.99% |
| Sep 30, 2025 | -110.72% |
| Jun 30, 2025 | 84.41% |
| Mar 31, 2025 | -98.92% |
| Dec 31, 2024 | 18.17% |
| Sep 30, 2024 | 204.57% |
| Jun 30, 2024 | -1,046.81% |
| Mar 31, 2024 | 15,313.85% |
| Dec 31, 2023 | -22.39% |
| Sep 30, 2023 | -31.40% |
| Jun 30, 2023 | 76.27% |
| Mar 31, 2023 | -7.17% |
| Dec 31, 2022 | -0.72% |
| Sep 30, 2022 | -21.87% |
| Jun 30, 2022 | 98.60% |
| Mar 31, 2022 | 53.27% |
| Dec 31, 2021 | 154.82% |
| Sep 30, 2021 | 738.88% |